Maureen Rischmueller

6.8k total citations · 1 hit paper
89 papers, 2.8k citations indexed

About

Maureen Rischmueller is a scholar working on Rheumatology, Physiology and Immunology. According to data from OpenAlex, Maureen Rischmueller has authored 89 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Rheumatology, 32 papers in Physiology and 26 papers in Immunology. Recurrent topics in Maureen Rischmueller's work include Salivary Gland Disorders and Functions (30 papers), Systemic Lupus Erythematosus Research (22 papers) and Rheumatoid Arthritis Research and Therapies (15 papers). Maureen Rischmueller is often cited by papers focused on Salivary Gland Disorders and Functions (30 papers), Systemic Lupus Erythematosus Research (22 papers) and Rheumatoid Arthritis Research and Therapies (15 papers). Maureen Rischmueller collaborates with scholars based in Australia, United States and Brazil. Maureen Rischmueller's co-authors include Tom P. Gordon, Sally A. Waterman, Susanna Proudman, James McCluskey, Sue Lester, Catherine Hill, Susan Lester, Aileen L. Pangan, Ricardo Machado Xavier and Susan Lester and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Immunological Reviews.

In The Last Decade

Maureen Rischmueller

88 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

2020 181 citations Maureen Rischmueller, Nasser Khan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maureen Rischmueller Australia	31	1.0k	902	703	612	455	89	2.8k
Theodoros Dimitroulas Greece	28	971 0.9×	413 0.5×	330 0.5×	727 1.2×	584 1.3×	173	2.6k
Margit Zeher Hungary	39	1.6k 1.6×	1.6k 1.8×	801 1.1×	1.1k 1.9×	264 0.6×	147	4.5k
Ilaria Cavazzana Italy	34	1.8k 1.7×	956 1.1×	439 0.6×	1.0k 1.6×	332 0.7×	107	3.5k
Doyt L. Conn United States	28	1.5k 1.5×	544 0.6×	294 0.4×	597 1.0×	649 1.4×	65	2.8k
Philippe Guilpain France	34	885 0.9×	814 0.9×	463 0.7×	962 1.6×	1.4k 3.0×	126	3.4k
Shin‐ya Kawashiri Japan	27	1.3k 1.3×	745 0.8×	294 0.4×	269 0.4×	375 0.8×	223	3.0k
Gabriella Szűcs Hungary	30	1.2k 1.2×	772 0.9×	181 0.3×	1.2k 1.9×	286 0.6×	122	3.1k
P. C. Limburg Netherlands	33	1.3k 1.2×	1.3k 1.4×	429 0.6×	213 0.3×	1.0k 2.2×	52	3.6k
Serge Steinfeld Belgium	21	1.7k 1.7×	1.3k 1.4×	763 1.1×	271 0.4×	162 0.4×	52	3.4k
Satoshi Yamasaki Japan	32	775 0.8×	793 0.9×	257 0.4×	332 0.5×	212 0.5×	188	3.1k

Countries citing papers authored by Maureen Rischmueller

Since Specialization

Citations

This map shows the geographic impact of Maureen Rischmueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Rischmueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Rischmueller more than expected).

Fields of papers citing papers by Maureen Rischmueller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Rischmueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Rischmueller. The network helps show where Maureen Rischmueller may publish in the future.

Co-authorship network of co-authors of Maureen Rischmueller

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Rischmueller. A scholar is included among the top collaborators of Maureen Rischmueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Rischmueller. Maureen Rischmueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Franke, Kyle B., et al.. (2025). Novel therapies in Sjögren’s disease: A systematic review of the literature. Best Practice & Research Clinical Rheumatology. 39(4). 102084–102084. 1 indexed citations

Kivitz, Alan, Alvin F. Wells, Herbert S. B. Baraf, et al.. (2023). Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study. Rheumatology and Therapy. 10(4). 901–915. 3 indexed citations

Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2017). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.. PubMed. 34 Suppl 100(5). 129–136. 16 indexed citations

Hao, Yanjie, Vivek Thakkar, Wendy Stevens, et al.. (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research & Therapy. 17(1). 7–7. 88 indexed citations

Hao, Yue, Wendy Stevens, Kathleen Morrisroe, et al.. (2014). A comparison of the predictive accuracy of three screening models (DETECT v.ESC/ERS v. ASIG) for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal. 44(11). 23–23. 1 indexed citations

Lester, Susan, Maureen Rischmueller, Peter J. Wormald, et al.. (2012). Sicca Symptoms and their Association with Chronic Rhinosinusitis in a Community Sample. The Open Rheumatology Journal. 6(1). 170–174. 8 indexed citations

Lester, Sue, Johannes C. Nossent, Catherine Hill, et al.. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Research & Therapy. 14(1). R28–R28. 35 indexed citations

Rischmueller, Maureen, et al.. (2011). Mortality in Patients with Biopsy-proven Giant Cell Arteritis -results from a South Australian Population Based study.. The Journal of Rheumatology. 38. 1 indexed citations

Nguyen, Anh Minh, et al.. (2011). Mortality in Patients with Biopsy-proven Giant Cell Arteritis: A South Australian Population-based Study. The Journal of Rheumatology. 38(10). 2215–2217. 40 indexed citations

10.

Hill, Catherine, Aidan Cole, Maureen Rischmueller, et al.. (2010). Risk of cancer in patients with biopsy-proven giant cell arteritis. Lara D. Veeken. 49(4). 756–759. 20 indexed citations

11.

Wechalekar, Mihir D., Maureen Rischmueller, Samuel Whittle, Simon Burnet, & Catherine Hill. (2010). Prolonged Remission of Chronic Reactive Arthritis Treated With Three Infusions of Infliximab. JCR Journal of Clinical Rheumatology. 16(2). 79–80. 15 indexed citations

12.

Tak, P. P., Rogier M. Thurlings, Ivan Nestorov, et al.. (2007). Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double‐blind, placebo‐controlled, dose‐escalating, single‐ and repeated‐dose study. Arthritis & Rheumatism. 58(1). 61–72. 171 indexed citations

13.

Downie‐Doyle, Sarah, et al.. (2007). Influence of CTLA4 Haplotypes on Susceptibility and Some Extraglandular Manifestations in Primary Sjogren’s Syndrome. Trauma Monthly. 2007(1). 83–92. 1 indexed citations

14.

Lester, Susan, et al.. (2007). Epistasis between the MHC and the RCAÎ± block in primary SjÃ¶gren syndrome. Annals of the Rheumatic Diseases. 67(6). 849–854. 12 indexed citations

15.

Downie‐Doyle, Sarah, et al.. (2006). Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjögren's syndrome. Arthritis & Rheumatism. 54(8). 2434–2440. 43 indexed citations

16.

Mullighan, Charles G., Susan L. Heatley, Peter Bardy, et al.. (2000). Lack of association between mannose-binding lectin gene polymorphisms and primary Sjögren's syndrome. Arthritis & Rheumatism. 43(12). 2851–2852. 14 indexed citations

17.

Couper, Jennifer, et al.. (2000). Toxic shock syndrome associated with newly diagnosed type I diabetes. Journal of Paediatrics and Child Health. 36(3). 279–282. 6 indexed citations

18.

McCluskey, James, A. Darise Farris, Catherine L. Keech, et al.. (1998). Determinant spreading: lessons from animal models and human disease. Immunological Reviews. 164(1). 209–229. 107 indexed citations

19.

Rischmueller, Maureen, Roger P. Davies, & Mark D. Smith. (1996). THREE YEAR FOLLOW-UP OF A CASE OF GIANT CELL ARTERITIS PRESENTING WITH A CHRONIC COUGH AND UPPER LIMB ISCHAEMIC SYMPTOMS. Lara D. Veeken. 35(8). 800–802. 10 indexed citations

20.

Gordon, Tom P., et al.. (1994). How Does Autoimmunity to La and Ro Initiate and Spread?. Autoimmunity. 18(2). 87–92. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact